Caitilin A. Hamill

Caitilin A. Hamill, Ph.D., currently serves as the Vice President of Regulatory Affairs at Tenaya Therapeutics. With a robust background in regulatory affairs, Caitilin has held notable positions such as Vice President of Regulatory Affairs at Orna Therapeutics and Vice President and Head of Global Regulatory Affairs at Medpace. Caitilin's expertise extends to advanced therapy regulatory consulting at Reg Omics and a senior role as Regulatory Affairs Director at IQVIA. Educationally, Caitilin holds an MBA in Finance from The Wharton School and completed the Food and Drug Administration Fellowship Training from 2008 to 2010.